In an adult patient with macrocytic anemia (Hb 11.3 g/dL, Hct 37.7 %, MCV 99 fL), low platelet count, elevated ferritin, low‑normal total iron‑binding capacity (TIBC), mild eosinophilia, and an elevated BUN/creatinine ratio, what is the most likely etiology and what management steps are recommended?

Macrocytic Anemia with Elevated Ferritin and Thrombocytopenia: Likely Anemia of Chronic Disease with Possible Bone Marrow Pathology

This patient does NOT have iron deficiency anemia—the elevated ferritin (337.3 ng/mL) and normal iron saturation (40%) definitively exclude it, and the macrocytic pattern points toward either vitamin B12/folate deficiency, bone marrow disease (myelodysplastic syndrome), or anemia of chronic disease. 1

Key Laboratory Interpretation

Why This Is NOT Iron Deficiency

• Ferritin 337.3 ng/mL is markedly elevated: Ferritin >150 μg/L is unlikely to occur with absolute iron deficiency, even in the presence of inflammation 1
• Iron saturation 40% is normal: Iron deficiency typically shows transferrin saturation <20% 1
• Low TIBC (233.6 μg/dL): Iron deficiency causes elevated TIBC, not low TIBC 1
• MCV 99 fL (macrocytic, not microcytic): Iron deficiency causes microcytosis (low MCV), not macrocytosis 1

Pattern Suggests Chronic Disease or Bone Marrow Disorder

• Macrocytic anemia (MCV 99 fL) with low-normal reticulocytes indicates inadequate bone marrow response 1
• Thrombocytopenia (110 × 10³/μL) raises concern for bone marrow pathology 1, 2
• Elevated RDW (16.6%) with macrocytosis suggests mixed population or dysplasia 1
• Elevated BUN/Cr ratio (40) with normal creatinine suggests prerenal state or GI bleeding 1

Most Likely Etiologies (In Order of Priority)

1. Myelodysplastic Syndrome (MDS)

The combination of macrocytic anemia, thrombocytopenia, elevated ferritin, and elevated RDW is highly suspicious for MDS 1, 2. MDS commonly presents with:

• Macrocytic anemia with normal or low reticulocytes 1, 2
• Cytopenias affecting multiple cell lines (bicytopenia or pancytopenia) 1
• Elevated ferritin from ineffective erythropoiesis and transfusion burden 2

2. Vitamin B12 or Folate Deficiency

Macrocytosis with low reticulocytes classically indicates megaloblastic anemia 1. Common causes include:

• Pernicious anemia, malabsorption, dietary deficiency 3, 4
• Can coexist with other pathology 1

3. Anemia of Chronic Disease with Functional Iron Deficiency

Elevated ferritin with low TIBC suggests chronic inflammation 1. However:

• The macrocytic pattern is atypical (ACD usually normocytic or microcytic) 1
• Mild eosinophilia (8.3%) may indicate parasitic infection, drug reaction, or inflammatory condition 1

4. Copper Deficiency

Rare but important cause of macrocytic anemia with neutropenia 5. Features include:

• Bicytopenia (anemia + neutropenia) with normal platelets 5
• This patient has thrombocytopenia, making copper deficiency less likely 5

Recommended Management Algorithm

Immediate Workup (Within 1-2 Weeks)

Step 1: Obtain vitamin levels and additional hematologic markers 1

• Vitamin B12 level (methylmalonic acid and homocysteine if B12 borderline) 1, 6
• Folate level 1
• Reticulocyte count (if not already done) 1
• Peripheral blood smear review for dysplasia, macro-ovalocytes, hypersegmented neutrophils 1, 3

Step 2: Assess for chronic disease and inflammation 1

• CRP or ESR (if not already done) 1
• LDH and haptoglobin to exclude hemolysis 1
• Liver function tests (already done—normal) 3, 6
• Thyroid function (TSH already done—normal) 3

Step 3: Evaluate for occult bleeding 1

• Stool occult blood testing 1
• Consider upper and lower GI evaluation if indicated by symptoms or risk factors 1
• The elevated BUN/Cr ratio may suggest GI blood loss 1

Urgent Hematology Referral (Within 1-2 Weeks)

Bone marrow aspiration and biopsy with cytogenetics is indicated given the combination of macrocytic anemia, thrombocytopenia, and elevated ferritin 1, 2. This is essential to:

• Rule out MDS or other primary bone marrow disorders 1, 2
• Assess for megaloblastic changes if B12/folate deficiency suspected 1, 3
• Evaluate iron stores and erythroid maturation 1

Treatment Approach Based on Findings

If B12 or folate deficiency confirmed:

• Initiate appropriate vitamin replacement 1, 4
• Recheck CBC in 4 weeks; expect hemoglobin rise ≥2 g/dL 1
• Investigate underlying cause (pernicious anemia, malabsorption) 1, 4

If MDS diagnosed:

• Risk stratification and treatment per hematology guidelines 1
• Consider hypomethylating agents (azacitidine, decitabine) for higher-risk disease 1
• Supportive care with transfusions and growth factors as needed 1

If anemia of chronic disease:

• Treat underlying inflammatory condition 1
• Consider erythropoiesis-stimulating agents if hemoglobin ≤10 g/dL and EPO <500 mU/mL 1

Critical Pitfalls to Avoid

Do NOT treat empirically with iron supplementation—this patient has iron overload (elevated ferritin), not deficiency, and iron therapy could worsen outcomes 1, 7

Do NOT delay bone marrow evaluation if initial vitamin levels are normal or borderline—the thrombocytopenia and macrocytosis pattern warrant definitive assessment for MDS 1, 2

Do NOT assume a single etiology—combined deficiencies (B12 + folate, or deficiency + MDS) can coexist and mask each other's typical MCV patterns 1

Monitor for progression—if diagnosis remains unclear after initial workup, repeat CBC in 4-6 weeks and maintain low threshold for bone marrow biopsy 1, 3